Genetic Technologies Limited (ASX:GTG)

Australia · Delayed Price · Currency is AUD

0.0390

0.00 (0.00%)

Oct 16, 2024, 1:07 PM AEST

Genetic Technologies Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	9.17	9.67	10.35	9.22	1.33	0.84
Revenue Growth	-5.17%	-6.52%	12.25%	590.65%	59.30%	3192.98%
Gross Profit	5.41	5.91	6.01	6.2	1.16	0.74
Operating Income	-9.79	-10.59	-10.42	-7.54	-7.42	-5.94
Net Income	-9.68	-12.02	-11.75	-7.13	-7.08	-6.29
Earnings Per Share	-0.07	-0.09	-0.12	-0.08	-0.08	-0.15
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Easydna	6.16	7.7	5.99	-
Affinitydna	1.37	0.94	-	-
Genetype / Corporate	2.1	2.1	3.62	1.74
Total	9.63	10.74	9.61	1.74

Cash & Debt

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Cash & Investments	1.01	1.04	7.87	11.74	20.9	14.22
Total Debt	0.5	0.88	0.53	0.65	0.2	0.48
Net Cash (Debt)	0.51	0.16	7.34	11.09	20.7	13.73
Net Cash Growth	212.37%	-97.76%	-33.86%	-46.41%	50.72%	528.52%
Net Cash Per Share	0.00	0.00	0.07	0.12	0.24	0.33

Cash Flow & CapEx

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Operating Cash Flow	-5.74	-9.68	-9.72	-5.66	-6.3	-5.71
Capital Expenditures	-0.01	-0.03	-0.02	-0.06	-0.75	-0.04
Free Cash Flow	-5.75	-9.71	-9.74	-5.72	-7.04	-5.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Gross Margin	59.00%	61.12%	58.10%	67.31%	87.23%	87.89%
Operating Margin	-106.74%	-109.52%	-100.66%	-81.84%	-556.03%	-708.77%
Pretax Margin	-141.18%	-124.24%	-115.09%	-77.71%	-530.26%	-751.29%
Profit Margin	-105.58%	-124.24%	-113.56%	-77.36%	-530.26%	-751.29%
FCF Margin	-62.69%	-100.41%	-94.13%	-62.09%	-527.79%	-686.29%

Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '26 Aug 8, 2026	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
PS Ratio	0.62	1.02	2.79	3.01	57.42	44.84